Cargando…

Editorial: New therapies in the treatment of sarcomas

Detalles Bibliográficos
Autores principales:	Gartland, Alison, Pasello, Michela, Lézot, Frédéric, Lamoureux, Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890148/ https://www.ncbi.nlm.nih.gov/pubmed/36742406 http://dx.doi.org/10.3389/fendo.2023.1137736

Ejemplares similares

Ribosomopathies: New Therapeutic Perspectives
por: Orgebin, Emilien, et al.
Publicado: (2020)

Simulated Interventions to Ameliorate Age-Related Bone Loss Indicate the Importance of Timing
por: Proctor, Carole J., et al.
Publicado: (2016)

Editorial: Xenotransplantation for the therapy of diabetes: A new look
por: Yamada, Kazuhiko, et al.
Publicado: (2023)

Editorial: Alveolar Bone: A Pivotal Role in Periodontal Disease Pathobiology and Treatment
por: Anagnostou, Fani, et al.
Publicado: (2022)

Editorial: Calcium and parathormone: an update on the clinical presentation and new therapies
por: Carsote, Mara, et al.
Publicado: (2023)

Editorial: New insights in diagnosis and therapy of hormone-dependent cancer
por: Rienzo, Monica, et al.
Publicado: (2023)

Editorial: New strategies in treatment of differentiated thyroid carcinoma
por: Carrillo, Jose Federico, et al.
Publicado: (2022)

Editorial: Childhood Rickets—New Developments in Epidemiology, Prevention, and Treatment
por: Simm, Peter J., et al.
Publicado: (2020)

Purinergic signalling in bone
por: Rumney, Robin M. H., et al.
Publicado: (2012)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018)

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
por: Lézot, Frédéric, et al.
Publicado: (2020)

Editorial: New Aspects in Hypogonadism
por: Dwyer, Andrew A., et al.
Publicado: (2020)

Editorial: What's New in Endocrinology?
por: Holly, Jeff M. P., et al.
Publicado: (2019)

Editorial: New Insights and Controversies in Diagnosis and Treatment of Adult Growth Hormone Deficiency
por: Mancini, Antonio, et al.
Publicado: (2022)

Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Editorial: Levothyroxine Therapy in Patients With Hypothyroidism
por: Antonelli, Alessandro, et al.
Publicado: (2021)

A Candidate Gene Association Study of Bone Mineral Density in an Iranian Population
por: Dastgheib, Seyed Alireza, et al.
Publicado: (2016)

Editorial: Wnt signaling in endocrine and metabolic disorders
por: Cailotto, Frederic, et al.
Publicado: (2023)

Editorial: Resistance to Medical Therapy in Pituitary Tumors
por: Auriemma, Renata S., et al.
Publicado: (2022)

Editorial: Targeted therapy in advanced thyroid cancer
por: Boucai, Laura
Publicado: (2022)

Editorial: New approaches for the discovery of GPCR ligands
por: Morales, Paula, et al.
Publicado: (2023)

Editorial: MicroRNAs as New Players in Endocrinology
por: Peng, Chun, et al.
Publicado: (2018)

Editorial: New insights in thyroid and Covid-19
por: Sgarbi, Jose Augusto, et al.
Publicado: (2022)

Editorial: “Thyroid Hormone in Brain and Brain Cells”
por: Flamant, Frédéric, et al.
Publicado: (2015)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: Insights in exercise and diabetes management
por: Cyriac, T., et al.
Publicado: (2022)

Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment
por: Neves, João Sérgio, et al.
Publicado: (2023)

Editorial: Rare musculoskeletal disorders: disease mechanisms and therapies
por: Seefried, Lothar, et al.
Publicado: (2023)

Editorial: Cell-Based Therapies for Diabetic Microvascular Complications
por: Bhatwadekar, Ashay D.
Publicado: (2015)

Editorial: Endocrine and metabolic diseases – genetic impact and therapies
por: Jéru, Isabelle, et al.
Publicado: (2022)

Editorial: New molecular targets involved in lung adenocarcinoma
por: Zhan, Xianquan, et al.
Publicado: (2023)

Editorial: New Perspectives on the Endocrinology of Physical Activity and Sport
por: Ackerman, Kathryn E., et al.
Publicado: (2021)

Editorial: Emerging receptors as new targets in health and disease
por: Dam, Julie, et al.
Publicado: (2022)

Editorial: Cardiac fat in metabolic and endocrine diseases
por: Soghomonian, Astrid, et al.
Publicado: (2023)

Absence of P2Y(2) Receptor Does Not Prevent Bone Destruction in a Murine Model of Muscle Paralysis-Induced Bone Loss
por: Agrawal, Ankita, et al.
Publicado: (2022)

Editorial: Cancer-related hypercalcemia and potential treatments
por: Scappaticcio, Lorenzo, et al.
Publicado: (2023)

Editorial: Radiofrequency Ablation as an Alternative to Conventional Treatment
por: Pagano, Loredana, et al.
Publicado: (2022)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
por: Rando, Maria Margherita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl89fkai4idh7eofb57i4f22q1